Apheresis Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

The global apheresis market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.59% during 2024-2032.

More Info:- https://www.imarcgroup.com/apheresis-market

1. Global Apheresis Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

2. About IMARC Group IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. Across the six major continents and 100+ countries, we work alongside our business partners as one team with a common ambition to achieve unparalleled results, gain a competitive edge, and transform industries. IMARC Group excels in understanding its clients’ business priorities and delivering tailored solutions that drive meaningful outcomes. Our client base spans over 3,000 organizations in the private, public, and social sectors, ranging from high-growth startups to Fortune 500 companies. We provide a comprehensive suite of market entry and expansion services. Our offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. These services are designed to assist companies in evaluating market opportunities, setting up new entities, navigating regulatory landscapes, boosting brand visibility, analyzing competitors, and optimizing procurement strategies.

3. Report Highlight and Description According to the latest report by IMARC Group, titled  "Apheresis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global apheresis market size reached US$ 2.9 Billion in 2023. Factors Affecting the Growth of the Apheresis Industry: Increasing Prevalence of Chronic Diseases: Chronic diseases, such as cancer, autoimmune disorders, and blood-related conditions, often require therapeutic interventions that involve removing harmful components from the blood. Apheresis procedures enable the selective removal of these components, thereby helping to manage the symptoms and progression of these diseases. Apheresis techniques are also used for diagnostic purposes in various chronic diseases. Apheresis can also help in analyzing specific blood components or identifying biomarkers associated with certain conditions, aiding in disease diagnosis and monitoring. Technological Advancements: Innovations in apheresis technology are leading to the development of more efficient systems for blood component separation. These advancements enable higher throughput, shorter procedure times, and increased collection yields, enhancing the overall efficiency of apheresis procedures.

4. Report Highlight and Description Modern apheresis machines incorporate sophisticated automation and control features that allow for precise manipulation of blood components. This precision ensures the accurate separation and collection of specific blood components, minimizing the risk of procedural errors and improving patient outcomes. Growing Demand for Blood Components: Apheresis procedures enable the selective collection of specific blood components, such as platelets, plasma, and white blood cells (WBCs). These components have diverse therapeutic applications in transfusion medicine, hematology, oncology, and immunology. Platelets play a crucial role in hemostasis and are frequently needed for patients with bleeding disorders, undergoing surgery, or receiving chemotherapy. Apheresis allows for the efficient collection of platelets from single donors, meeting the high demand for these blood products. Request for a PDF sample of this report: https://www.imarcgroup.com/apheresis-market/requestsample

5. Report Description Global Apheresis Market Trends : There is a growing emphasis on personalized or precision medicine approaches, which require tailored blood component therapies collected through apheresis procedures to meet individual patient needs. Apheresis procedures are finding expanding therapeutic applications beyond traditional uses, including the treatment of neurological disorders, organ transplantation, and immune-mediated diseases, driving market diversification. Rising awareness among healthcare professionals and patients about the benefits of apheresis procedures is leading to higher acceptance and utilization of these techniques, contributing to the market growth. View Report TOC, Figures and Tables : https://www.imarcgroup.com/apheresis-market

6. Report Segmentation Breakup by Component: Plasma (Plasmapheresis) Platelets (Plateletpheresis) Leukocytes (Leukapheresis or Leukopheresis ) Lymphocytes ( Lymphopheresis or Lymphapheresis ) RBC's ( Erythropheresis ) Breakup by Product: Devices Disposables and Reagents Software Breakup by Technology: Centrifugation

7. Report Segmentation Membrane Separation Selective Adsorption Breakup by Procedure: Donor/Automated Apheresis Therapeutic Apheresis Breakup by Application: Renal Disorders Hematological Disorders Neurological Disorders Autoimmune Disorders Others

8. Report Segmentation Breakup by End User: Blood Centers Hospitals Others Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

9. Competitive Landscape with Key Players Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation) B. Braun SE Charles River Laboratories International Inc. Fresenius Medical Care AG & Co. KGaA Haemonetics Corporation Haier Biomedical Kaneka Corporation Medica S.p.a . Miltenyi Biotec Nikkiso Co. Ltd. Sb- Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) Terumo Bct Inc. (Terumo Corporation).

10. Key Questions Answered in the Report

11. Key Questions Answered in the Report

12. Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Apheresis Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Component 6.1 Plasma (Plasmapheresis) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Platelets (Plateletpheresis) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Leukocytes (Leukapheresis or Leukopheresis ) 6.3.1 Market Trends 6.3.2 Market Forecast        

13. Table of Contents 6.4 Lymphocytes ( Lymphopheresis or Lymphapheresis ) 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 RBC's ( Erythropheresis ) 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Product 7.1 Devices 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Disposables and Reagents 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Software 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Technology 8.1 Centrifugation 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Membrane Separation 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Selective Adsorption 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Procedure 9.1 Donor/Automated Apheresis 9.1.1 Market Trends 9.1.2 Market Forecast For more information, visit : https://www.imarcgroup.com/apheresis-market/toc

14. Partial List of Clients

15. Partial List of Clients

16. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

17. Contact Us Visit us at : https://www.imarcgroup.com [phone] [email protected] Stay With Us: